HAAO
3-hydroxyanthranilate 3,4-dioxygenase
Also known as: 3HAO_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P46952
- Gene
- HAAO
- Ensembl
- ENSG00000162882
- Chromosome
- 2
- Canonical length
- 286 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
OverviewNCBI Gene
3-Hydroxyanthranilate 3,4-dioxygenase is a monomeric cytosolic protein belonging to the family of intramolecular dioxygenases containing nonheme ferrous iron. It is widely distributed in peripheral organs, such as liver and kidney, and is also present in low amounts in the central nervous system. HAAO catalyzes the synthesis of quinolinic acid (QUIN) from 3-hydroxyanthranilic acid. QUIN is an excitotoxin whose toxicity is mediated by its ability to activate glutamate N-methyl-D-aspartate receptors. Increased cerebral levels of QUIN may participate in the pathogenesis of neurologic and inflammatory disorders. HAAO has been suggested to play a role in disorders associated with altered tissue levels of QUIN. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
286 residues, UniProt reviewed canonical sequence.
>P46952|HAAO
1 MERRLGVRAW VKENRGSFQP PVCNKLMHQE QLKVMFIGGP NTRKDYHIEE GEEVFYQLEG
61 DMVLRVLEQG KHRDVVIRQG EIFLLPARVP HSPQRFANTV GLVVERRRLE TELDGLRYYV
121 GDTMDVLFEK WFYCKDLGTQ LAPIIQEFFS SEQYRTGKPI PDQLLKEPPF PLSTRSIMEP
181 MSLDAWLDSH HRELQAGTPL SLFGDTYETQ VIAYGQGSSE GLRQNVDVWL WQLEGSSVVT
241 MGGRRLSLAP DDSLLVLAGT SYAWERTQGS VALSVTQDPA CKKPLGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HAAO can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 277 nTPM
Expression across tissuesHPA
Tissue
- liver: 277 nTPM
- kidney: 39 nTPM
- blood vessel: 39 nTPM
- small intestine: 38 nTPM
- pancreas: 25 nTPM
- duodenum: 22 nTPM
Single-cell type
- hepatocytes: 296 nCPM
- enterocytes: 263 nCPM
- epicardial cells: 57 nCPM
- myosatellite cells: 47 nCPM
- enteric transient amplifying cells: 44 nCPM
- proximal tubule cells: 44 nCPM
Immune cell
- myeloid DC: 23 nTPM
- eosinophil: 19 nTPM
- classical monocyte: 17 nTPM
- intermediate monocyte: 11 nTPM
- basophil: 8 nTPM
- plasmacytoid DC: 7.7 nTPM
Brain region
- choroid plexus: 4.5 nTPM
- midbrain: 2.9 nTPM
- hypothalamus: 2.5 nTPM
- medulla oblongata: 2.5 nTPM
- white matter: 2.5 nTPM
- cerebellum: 2.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HAAO.
Disease | AllUniProt
Conditions HAAO is implicated in, by any mechanism.
- Vertebral, cardiac, renal, and limb defects syndrome 1 (VCRL1) MIM:617660
Disease | GeneticClinVar
12 pathogenic / likely-pathogenic of 82 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Vertebral, cardiac, renal, and limb defects syndrome 1
- Congenital NAD deficiency disorder
- Monogenic hearing loss
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.14
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.18
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 'de novo' NAD+ biosynthetic process from L-tryptophan
- anthranilate metabolic process
- L-tryptophan catabolic process
- NAD+ biosynthetic process
- neuron cellular homeostasis
- quinolinate biosynthetic process
- response to cadmium ion
- response to zinc ion
- quinolinate metabolic process
Molecular functions
- electron transfer activity
- ferrous iron binding
- 3-hydroxyanthranilate 3,4-dioxygenase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RmlC-like cupin domain superfamily
- RmlC-like jelly roll fold
- 3-hydroxyanthranilic acid dioxygenase
- 3-hydroxyanthranilate 3, 4-dioxygenase, metazoan
- 3-hydroxyanthranilic acid dioxygenase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HAAO as an antibody target. Whether an autoantibody or antibody against HAAO could matter depends on whether native HAAO is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HAAO is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HAAO as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...